Kristina Jankovic, MD· @JankovicK · X·· 2 days agoScore70
Body
Encouraging 6-year #NATALEE results presented at #ESMO26 ! 🎯
Adjuvant ribociclib + NSAI shows a deepening iDFS benefit and favourable OS results in HR+/HER2− early #BreastCancer
@OncoAlert
353 views · 5 likes · 4 reposts · 0 replies
Conference abstracts
LBA25matched by Proffered paper 1: Breast cancer, early and advanced stage
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgOral abstract #BreastCancer session at #ESMO26: updated data from NATALEE trial simultaneously published in @Annals_Oncology @OncoAlert @myESMO在 X 查看被引用的帖子
Source: Kristina Jankovic, MD · x.com